Skip to main content

Incannex Healthcare Limited (IXHL)

Incannex Healthcare will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap452.36M
Revenue (ttm)1.37M
Net Income (ttm)-4.14M
Shares Out45.24M
EPS (ttm)-0.09
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Earnings Daten/a

About IXHL

Since 2019, Incannex Healthcare has been conducting research and development for synthetic cannabidiol pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. Our mission is to create first-in-class pharmaceutical drugs and therapies for patients that we believe have unmet medical needs. In particular, we are developing three unique pharmaceutical compositions to target five indications: obstructive sleep apnea, traumatic brain injury/concussion, rheumatoid arthritis, inflammatory bowel disease and in...

IndustryPharmaceutical Preparations
CEOJoel Latham
Stock ExchangeNASDAQ
Ticker SymbolIXHL
Full Company Profile

Financial Performance

Financial numbers in millions AUDFinancial Statements


Incannex Healthcare (ASX:IHL) files registration statement for proposed IPO in US

Incannex Healthcare (ASX:IHL) has filed a registration statement with the United States' Securities and Exchange Commission in relation to a proposed US public offering (IPO).

3 months ago - The Market Herald

Incannex Healthcare IPO Registration Document (S-1)

Incannex Healthcare Limited has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC